Search for: "In Re C & P Co." Results 241 - 260 of 1,261
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
22 Mar 2010, 7:57 am by Ron (mailto:ron@prismlegal.com)
When you look at law firm growth though, it was driven by demand, not by need to re-assure associates. [read post]
24 Aug 2012, 6:08 am
Sob o aspecto econômico, ele apresentou dados que indicam que, somente no SUS, foram gastos, em 2011 e 2012, R$ 291,871 milhões com o tratamento quimioterápíco, cirurgias oncológicas, internações em unidades de terapia intensiva (UTIs) e leitos, sem incluir tratamentos ambulatoriais. [read post]
19 Aug 2021, 4:36 am by Chukwuma Okoli
Witten by Orji A Uka (Senior Associate at ALP NG & Co) and Damilola Alabi (Associate at ALP NG & Co) Introduction The issuance and service of an originating process are fundamental issues that afford or rob a court of jurisdiction to adjudicate over a matter. [read post]
7 Dec 2022, 4:00 am by Administrator
Rep. 66b, 77 E.R. 1025, at p. 67b and p. 1026, and Roger Earl of Rutland’s Case (1608), 8 Co. [read post]
10 Jul 2008, 5:31 pm
Robbins Co., 577 P.2d 975, 978 (Wash. 1978).Wyoming: Rohde v. [read post]
17 Oct 2022, 2:47 pm
 Vertical Agreements (Swiss Law) Distribution Agreements (Swiss Law)   Notion de contrat de distribution (c. 7.1.1.) [read post]
23 Mar 2017, 3:02 pm by Rebecca Tushnet
General challenge w/non word marks is we don’t have good system for forcing the P to articulate its claim. [read post]
30 Jun 2014, 4:26 pm by Joey Fishkin
 None of these—neither (a), (b), nor (c)—is really a legal claim. [read post]
15 Mar 2019, 1:23 pm by skelly
While you were off changing the industry, you may have missed these important developments: India-based online insurance startup Acko General Insurance Ltd. raised $65 million USD from Flipkart co-founder Binny Bansal, RPS Ventures Inc. and Intact Ventures Inc. in a series C financing round. [read post]
16 Sep 2009, 5:05 am by MPC
Both the doses of E-LL-01 have shown significant reduction (P < 0.05) in LDL-C, VLDL-C, and Total Cholesterol at the end of the study as compared to baseline. [read post]